Charlotte Fribbens Selected Research

Charlotte Fribbens Research Topics

8	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2016
6	Neoplasms (Cancer) 01/2023 - 01/2016
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2023 - 01/2023
2	COVID-19 01/2021 - 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Adenocarcinoma 01/2022
1	Hemorrhage 01/2022
1	Cytokine Release Syndrome 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Disease Progression 01/2020
1	Infections 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 11/2017

3	Fulvestrant (Faslodex)FDA Link 10/2020 - 01/2016
3	Circulating Tumor DNAIBA 01/2020 - 01/2016
3	Estrogen ReceptorsIBA 01/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
2	COVID-19 VaccinesIBA 01/2023 - 01/2021
2	Hormones (Hormone)IBA 10/2020 - 01/2016
2	Aromatase InhibitorsIBA 10/2020 - 01/2016
2	exemestane (Aromasin)FDA Link 10/2020 - 01/2016
2	palbociclibIBA 01/2018 - 01/2016
2	Cell-Free Nucleic AcidsIBA 11/2017 - 01/2016
1	ParaffinIBA 01/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	VaccinesIBA 01/2023
1	ibrutinibIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	BNT162 VaccineIBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	SteroidsIBA 01/2021
1	CytokinesIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2017
1	PlatinumIBA 11/2017
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2016

8	Therapeutics 01/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 04/2023 - 01/2022